Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Naglazyme

Galsulfase

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Naglazyme:

BioPortfolio Logo
Particles Detected in Vials from Genzyme's Plant Not Expected to Impact Aldurazyme or Naglazyme 13th November, 2009 BioMarin Pharmaceutical Inc.
NOVATO, Calif., Nov. 13 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that Genzyme notified the company that, in rare circumstances, it has detected foreign
BioMarin Announces Third Quarter 2009 Financial Results 28th October, 2009 BioMarin Pharmaceutical Inc.
Financial Highlights ($ in millions, except per share data) Item Q3 2009 Q3 2008 Comparison Total BioMarin Revenue $80.8
BioMarin to Present at the Morgan Stanley Healthcare Conference 8th September, 2009 BioMarin Pharmaceutical Inc.
NOVATO, Calif., Sept. 8 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will present a company
BioMarin to Host Second Quarter 2009 Financial Results Conference Call and Webcast on Thursday, July 30 at 5:00 p.m. ET (23:00 CET) 1st July, 2009 BioMarin Pharmaceutical Inc.
NOVATO, Calif., July 1 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will host a conference
Temporary Production Interruption at Allston Landing Manufacturing Facility Has No Impact on Aldurazyme 16th June, 2009 BioMarin Pharmaceutical Inc.
NOVATO, Calif., June 16 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the temporary interruption of bulk production at Genzyme's Allston Landing

Companies working in the area of Naglazyme from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

BioMarin Pharmaceutical

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, focusing on product candidates that:

* Address currently unmet medical...
www.bmrn.com/        View full profile
Thumbshot

This page has been viewed 33 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Naglazyme across BioPortfolio, or for Naglazyme Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.